Fruitful Registry
Home › Medical
Omnipod 5 App icon
US flag US
1 of 1 storefronts
Content in en-US
1.7k Ratings
3.6
★★★★
Age Rating
4+
Years
Language
EN
Size
133
MB

Information

Apple ID1528575090
Bundle IDcom.insulet.omnipod.icontroller
SellerSeller
Min iOS17.2
Device familiesiphone
Released2024-10-29
Copyright©2026 Insulet Corporation
WebsiteLink ↗
Privacy policyLink ↗

Preview 1 platform

iPhone 6 images

iPhone screenshot
iPhone screenshot
iPhone screenshot
iPhone screenshot
iPhone screenshot
iPhone screenshot

What’s New Version 2.2.1

• Introduce a new 100 mg/dL target glucose expanding the current range to 100–150 mg/dL in 10 mg/dL increments • Automated Delivery Restriction (ADR) no longer requires users to exit Automated Mode, the upper bound constraint notification period has been extended from 1 to 2 hours, permitted system adjustment of insulin delivery when upper bound limit is reached within active safety constraints • Bug Fixes

Description

Omnipod® 5 is the only FDA cleared, tubeless automated insulin delivery system that integrates with Dexcom G6 and G7 CGM and automatically adjusts insulin delivery to manage blood glucose with no multiple daily injections and zero fingersticks*. Simple and automated insulin delivery with the Omnipod 5 System is made possible with the Omnipod 5 Pod, the Omnipod 5 App on an Insulet-provided Controller or on your personal compatible smartphone** and the Dexcom G6 and G7 CGM. The Omnipod 5 App allows you to select a basal profile, target glucose, deliver a bolus, activate, and deactivate the Pod, connect with the Dexcom G6 and G7 CGM, and more. * Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings ** For a list of the latest compatible smartphones, please visit: https://www.omnipod.com/compatibility Intended Use: The Omnipod 5 App is part of the Omnipod 5 Automated Insulin Delivery System. The Omnipod 5 System is indicated for use by individuals with Type 1 diabetes mellitus in persons 2 years of age and older and for adults with Type 2 diabetes. The Omnipod 5 System is intended for single patient, home use and requires a prescription. The Omnipod 5 System is compatible with the following U-100 insulins: NovoLog®, Humalog®, and Admelog®. Refer to the Omnipod® 5 Automated Insulin Delivery System User Guide for complete safety information including indications, contraindications, warnings, cautions, and instructions. Do not use the Omnipod 5 App without receiving the proper training. This app store should not be used as your first point of contact to resolve technical or customer services issues. In order to protect your privacy and personal information, and to promptly resolve any technical or customer services issues you are having with any Insulet product, please contact Insulet customer support at 1-800-591-3455 or at Omnipod.com/contact-us. Disclaimer: You must seek a doctor’s advice in addition to using this app and before making any medical decisions. ©2026 Insulet Corporation. Omnipod, SmartAdjust, Podder, PodderCentral, the Omnipod logo, and Simplify Life are trademarks or registered trademarks of Insulet Corporation. All rights reserved. Dexcom and Dexcom G6 and G7 are registered trademarks of Dexcom, Inc. and used with permission. The use of third-party trademarks does not constitute an endorsement or imply a relationship or other affiliation. All other trademarks are the property of their respective owners.

Accessibility

ipadiphonemacrealityDevicetvoswatch

Version history 7 versions

Build 885825113v2.2.12026-06-03 15:34:42
• Introduce a new 100 mg/dL target glucose expanding the current range to 100–150 mg/dL in 10 mg/dL increments • Automated Delivery Restriction (ADR) no longer requires users to exit Automated Mode, the upper bound constraint notification period has been extended from 1 to 2 hours, permitted system adjustment of insulin delivery when upper bound limit is reached within active safety constraints • Bug Fixes
Build 879881468v2.1.02025-12-03 16:07:15
• Bug fixes and performance enhancements • Update to app reauthentication requirements • Update to the bolus screen to include adjusted for sensor calculation
Build 877849106v2.0.42025-09-15 14:08:37
* Performance enhancements and bug fixes
Build 874306354v2.0.22025-06-10 11:39:32
• Integration with Dexcom G7 CGM
Build 871105245v1.1.62025-01-13 15:03:18
• Bug fixes and performance enhancements
Build 870060775v1.1.52024-11-07 15:06:10
Update to allow the Omnipod 5 App to be accessed by a wider age range.
Build 837450373v1.1.42024-10-29 14:04:20

No pricing data captured yet — comparisons appear once the app has paid storefronts or in-app purchases.

Availability 1 of 1 storefronts

RegionLanguagePriceRatingsAvgVersion
US en-USFree1.7k3.62.2.1

Change log 10 changes · US

releaseNotes updated
• Introduce a new 100 mg/dL target glucose expanding the current range to 100–150 mg/dL in 10 mg/dL increments • Automated Delivery Restriction (ADR) no longer
description updated
Omnipod® 5 is the only FDA cleared, tubeless automated insulin delivery system that integrates with Dexcom G6 and G7 CGM and automatically adjusts insulin deliv
name updated
Omnipod 5 App
Version 2.2.1 released
• Introduce a new 100 mg/dL target glucose expanding the current range to 100–150 mg/dL in 10 mg/dL increments • Automated Delivery Restriction (ADR) no longer requires users to exit Automated Mode, the upper bound constraint notification
Version 2.1.0 released
• Bug fixes and performance enhancements • Update to app reauthentication requirements • Update to the bolus screen to include adjusted for sensor calculation
Version 2.0.4 released
* Performance enhancements and bug fixes
Version 2.0.2 released
• Integration with Dexcom G7 CGM
Version 1.1.6 released
• Bug fixes and performance enhancements
Version 1.1.5 released
Update to allow the Omnipod 5 App to be accessed by a wider age range.
Version 1.1.4 released
expanded screenshot